Singaporeans Raise SGD 2.86 Million for an Indian-descent Toddler Suffering from Spinal Muscular Atrophy

The one-time gene therapy for children with SMA, which costs around SGD 2.9 million was approved by the United States Food and Drug Administration in 2019.

from Top World News- News18.com https://ift.tt/384bigl